According to ScienceDaily, researchers have identified an unexpected genetic connection: mutations associated with blood cancers may trigger Alzheimer's disease by promoting excessive inflammation in brain cells. The discovery suggests new avenues for diagnosis through blood tests and potentially opens the door to treating Alzheimer's with approaches originally developed for cancer medicine.

Listen to this story

Hear this and more stories in a personalized audio briefing.

Open The Chonkerton